Kanichi Research Services

Seed Investment

Kanichi Research Services are developing novel non-invasive diagnostic systems that measure analytes in exhaled breath for the rapid detection and diagnosis of a range of diseases. The lead product is a low-cost, disposable, point of care test for the detection and diagnosis of Helicobacter Pylori (H. pylori), a bacterial infection in the gut which can lead to stomach ulcers and stomach cancer.

Kanichi's breath sensor technology has huge market potential with numerous advantages over current diagnostic tests. http://breathsensing.com

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200